A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2002
12/12/2002	US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002	US20020188009 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
12/12/2002	US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187998 Local ophthalmic agent for treatment of ocular inflammation
12/12/2002	US20020187991 Barbituric acid derivatives
12/12/2002	US20020187989 Preventive or therapeutic drugs for various eosinophilia-related diseases containg chymase inhibitors as the active ingredient
12/12/2002	US20020187976 New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
12/12/2002	US20020187930 Substances and their uses
12/12/2002	CA2449825A1 Use of an antioxidant for treating and/or preventing surface ocular disorders
12/12/2002	CA2449466A1 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449077A1 Epothilone derivatives
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2447480A1 Pyranoindazoles and their use for the treatment of glaucoma
12/12/2002	CA2447479A1 Novel arylaminopropane analogues and their use for the treatment of glaucoma
12/12/2002	CA2447156A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	CA2412652A1 Remedies for allergic diseases and process for producing the same
12/11/2002	EP1264829A1 Oxygen-containing heterocyclic compounds
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263953A2 Novel family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263742A1 Oxazolidinone thioamides with piperazine amide substituents
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263504A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina
12/11/2002	EP1263434A1 Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1263363A1 Colored visco-elastic composition
12/11/2002	EP1131325B1 [pyrrole]naphthopyranes, their preparation, compositions and (co)polymer matrices containing them
12/11/2002	EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
12/11/2002	EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives
12/11/2002	CN1384752A Remedies for nervous diseases
12/11/2002	CN1383892A Eye medicament
12/10/2002	US6492552 Disulfide derivatives useful for treating allergic diseases
12/10/2002	US6492497 Specific binding members for TGFbeta1
12/10/2002	US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
12/10/2002	US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492361 Antibiotic compositions and methods for using same
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002	CA2074580C Solid pharmaceutical composition for oral administration containing dapiprazole
12/08/2002	CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002	CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/05/2002	WO2002097116A2 Delivery system for nucleic acids
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096887A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002	WO2002096883A1 Tricyclic compounds useful as angiotensin ii agonists
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002	WO2002096864A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	WO2002096855A2 Anticholinergic compounds and methods of use
12/05/2002	WO2002096453A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	WO2002096432A2 Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002096419A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	WO2002096418A1 Pirenzepine ophthalmic gel
12/05/2002	WO2002096408A1 Coenzyme q and eicosapentaenoic acid (epa)
12/05/2002	WO2002096367A2 Targeted multivalent macromolecules
12/05/2002	WO2002096363A2 Method for treating fibrotic diseases or other indications
12/05/2002	WO2002096362A2 Method for treating fibrotic diseases or other indications vi
12/05/2002	WO2002096360A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	WO2002096318A2 Method for treating glaucoma v
12/05/2002	WO2002096317A2 Method for treating glaucoma vi
12/05/2002	WO2002087557A8 Method for treating retina or photoreceptor degeneration
12/05/2002	WO2002081415A3 Method for inhibiting metap2
12/05/2002	WO2002065978A3 Functional agent for decomposing nicotine and method of preparing the same
12/05/2002	WO2002062798A3 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
12/05/2002	WO2002047728A3 Treatment of posterior capsule opacification
12/05/2002	WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof

1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 531